Epigenetic modifiers in normal and aberrent erythropoeisis is a research paper published in Seminars in Hematology (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: K00 CA223044
NCI NIH HHS
Grant: F99 CA223044
NHLBI NIH HHS
Grant: P01 HL146372
National Institutes of Health
Grant: 5K00CA223044-05
Leveraging epigenetic and epitranscriptomic aberrations in cancer to identify molecular targets for designing therapy
National Institutes of Health
Grant: 5P01HL146372-04
Targeting Enzymatic Regulation of Fetal Hemoglobin Repression
National Institutes of Health
FWCI
0.07
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords